Synapse Medicine provides the most advanced AI solutions for #Healthcare and drugs prescriptions.
Synapse Medicine has raised €35M across 3 funding rounds from 5 investors, most recently a Series B round in Mar 2022. Based in Bordeaux, France; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2022-03-01 | Series B | €25M | BNP Paribas Development,Fleur Pellerin investment fund,Korelya Capital,MACSF,XAnge | View deal → |
| 2020-07-06 | Other | €7.1M | MACSF | View deal → |
| 2019-01-01 | Seed | €2.5M | XAnge | View deal → |
